News, Analysis & Insights on Nutrition, Supplements, and Health
Millions of people suffer from depression across the globe. According to the National Alliance on Mental Illness, 1 in 5 adults in the United States experience mental illness each year. The most common treatment methods for depression are antidepressant...
French biomarine company Algaia, SA, just announced it has appointed Frederic Faure, one of the co-founders of the company, as its new CEO. At the top of Faure’s to-do list: Accelerating and expanding the company’s sustainability plan. The new CEO said...
Hawaiian algae producer Cyanotech Corporation has posted a slim profit in its year end earnings report, mostly through aggressive cost cutting. That contrasted with a sharp loss for the previous year.
Embattled supplement retailer GNC has started its passage through Chapter 11 bankruptcy, with some investment experts and brand owners bullish about the new GNC that will emerge from the process.
Study findings involving Irish Travellers questions what a healthy microbiome is, as researchers identify non-dietary factors, which determine the gut’s make-up and its link with metabolic disease risk.
Calanus Oil contributes to the prevention of obesity-induced low-grade inflammation and associated metabolic disturbances by acting as potent stimulators of the GPR120 receptor, which is associated with reduced inflammation, according to a new review.
South Korea is proposing to add in ‘precautions for use’ warnings for nutraceuticals containing nine kinds of ingredients, including vitamins and potassium. It is also proposing new testing methods for vitamins.
See June's 10 most read stories, including the vegan supplement market in India, krill oil product recall in South Korea, and more.